About Dicle University Faculty of Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Eli Lilly and Company
5
Loxo Oncology, Inc.
2
Amgen
1
Boehringer Ingelheim
1
Firat University
1
Pfizer
1
Clinical Trials at Dicle University Faculty of Medicine
During the past decade, Dicle University Faculty of Medicine conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer
2014-02-21
2018-11-25
Completed
174
Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC
2015-05-11
2017-11-20
Completed
102
Associations of Alveolar Bone Loss and Interleukin-1β Levels in One and Two Stage Surgical Procedures
2010-09-01
2011-06-01
Completed
40
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
2020-02-17
2027-07-01
Active, not recruiting
250
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
2020-08-24
2027-12-30
Active, not recruiting
800
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Dicle University Faculty of Medicine" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Eli Lilly and Company" with 5 trials
sponsored, "Loxo Oncology, Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Boehringer Ingelheim"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dicle University Faculty of Medicine"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Dicle University" with 1 trials as a collaborator and "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Dicle University Faculty of Medicine
According to Clinical.Site data, the most researched conditions in "Dicle University Faculty of Medicine" are
"Breast Neoplasms" (3 trials), "Neoplasm Metastasis" (3 trials), "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Non-small Cell Lung Cancer (NSCLC)" (2 trials). Many other conditions were trialed in "Dicle University Faculty of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Dicle University Faculty of Medicine
Most popular intervention types in "Dicle University Faculty of Medicine" are "Drug" (17 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Carboplatin" (4 trials), "Placebo" (4 trials), "Abemaciclib" (3 trials) and "Cisplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Dicle University Faculty of Medicine
The vast majority of trials in "Dicle University Faculty of Medicine" are
18 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Dicle University Faculty of Medicine
Currently, there are NaN active trials in "Dicle University Faculty of Medicine".
undefined are not yet recruiting,
10 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Dicle University Faculty of Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dicle University Faculty of Medicine, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Dicle University Faculty of Medicine
Dicle University Faculty of Medicine has several departments that took part in Clinical trials: "Dicle University Medical Faculty" - 12 trials, "Dicle Uni Medical Faculty; Internal Medicine" - 4 trials, "Dicle University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology" - 2 trials
Departments List
Name
City
Trials